KESHO - Kenya Society of Hematology & Oncology

02/09/2026

What does progress in breast cancer care look like in clinical practice?⁣
⁣
At the 5th International Breast Cancer Symposium, specialists from across the region and beyond will examine the developments influencing breast oncology today.⁣
⁣
The scientific programme will explore:⁣
⁣
🔹 Advances in early breast cancer treatment⁣
🔹 The expanding role of antibody drug conjugates⁣
🔹 Evolving strategies for HER2 positive breast cancer⁣
🔹 Contemporary breast surgery and surgical de-escalation⁣
🔹 Clinical challenges and research opportunities in lobular breast cancer⁣
🔹 Survivorship, supportive care and multidisciplinary collaboration⁣
🔹 Clinical trial participation and global research partnerships⁣
⁣
The symposium is designed for oncologists, radiation oncologists, surgical oncologists, gynecologists, radiologists, oncology nurses, geneticists, allied health professionals, students, residents and early career physicians interested in .⁣
⁣
KESHO joins the symposium as a Supporting Society.⁣
⁣
📅 25 and 26 September 2026⁣
📍 Cleveland Clinic Abu Dhabi, UAE⁣
💳 Standard registration: USD 70⁣
⁣
𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐡𝐞𝐫𝐞: https://breastcancer-symposium.com/attend/⁣
⁣
⁣

15/08/2026

A cancer conversation can carry far more than clinical information.

It may involve fear, grief, difficult treatment decisions, family dynamics, questions about prognosis or information a patient has already encountered online or through AI.

These realities shaped the KESHO × Willow Health Media Patient-Centered Communication Training held at Fairview Hotel, Nairobi.

Across the day, participants explored how to break bad news with empathy, communicate complex information in plain language, support shared decision-making and navigate culture, health literacy, grief and end-of-life conversations.

One reflection captured the heart of the programme:

“Communication is part of cancer treatment.”

The training was highly interactive, with role plays, simulated consultations, practical exercises and feedback helping move communication from theory into practice.

Thank you to everyone who joined us and contributed to the discussions and shared learning.

We are also grateful to AstraZeneca and AAR for their support in making the program possible.

11/08/2026

Africa’s cancer diagnostic challenge is not only about access to new technology. It is also about whether pathology services, patient data, referral pathways and clinical teams are connected well enough to turn a diagnosis into timely care.⁣
⁣
This week’s KESHO CME moves beyond the promise of artificial intelligence to examine the systems required for it to make a meaningful difference.⁣
⁣
𝐃𝐫. 𝐀𝐫𝐯𝐢𝐧𝐝 𝐑𝐚𝐨 will explore governance, large language models and the connected future of AI-powered cancer care. 𝐃𝐫. 𝐉𝐨𝐬𝐡𝐮𝐚 𝐊𝐢𝐛𝐞𝐫𝐚 will address the digital diagnostic infrastructure needed to support AI-enabled precision cancer care.⁣
⁣
The discussion will be moderated by 𝐃𝐫. 𝐀𝐧𝐧𝐞 𝐊𝐨𝐫𝐢𝐫, Senior Research Scientist at the Kenya Medical Research Institute.⁣
⁣
𝐅𝐫𝐨𝐦 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 𝐭𝐨 𝐂𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐂𝐚𝐧𝐜𝐞𝐫 𝐂𝐚𝐫𝐞⁣
⁣
📅 Thursday, 13 August 2026⁣
⏰ 7:00 PM to 8:30 PM EAT⁣
🎓 CPD accredited⁣
⁣
𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐡𝐞𝐫𝐞:⁣
https://us02web.zoom.us/webinar/register/5415994631625/WN_WhGET8noRR6JTLnJSHh9cA⁣
⁣

05/08/2026

𝐂𝐨𝐮𝐥𝐝 𝐫𝐞𝐜𝐨𝐠𝐧𝐢𝐳𝐢𝐧𝐠 𝐭𝐡𝐞 𝐞𝐚𝐫𝐥𝐲 𝐬𝐢𝐠𝐧𝐬 𝐨𝐟 𝐥𝐮𝐧𝐠 𝐜𝐚𝐧𝐜𝐞𝐫 𝐬𝐚𝐯𝐞 𝐬𝐨𝐦𝐞𝐨𝐧𝐞 𝐲𝐨𝐮 𝐥𝐨𝐯𝐞?⁣
⁣
TV presenter 𝐒𝐚𝐦 𝐀𝐦𝐚𝐧𝐢 sits down with KESHO President 𝐃𝐫 𝐆𝐥𝐚𝐝𝐰𝐞𝐥𝐥 𝐊𝐢𝐚𝐫𝐢𝐞 and lung cancer survivor 𝐄𝐬𝐭𝐡𝐞𝐫 𝐍𝐠’𝐚𝐧𝐠’𝐚 for an open and important conversation about lung cancer in Kenya.⁣
⁣
𝐃𝐫 𝐊𝐢𝐚𝐫𝐢𝐞 explains the warning signs, risk factors and importance of seeking medical attention early. Esther shares her courageous journey through diagnosis and recovery, offering hope to patients, survivors and their families.⁣
⁣
Please watch, learn and share. This conversation could help someone recognize the signs and seek care sooner.⁣
⁣
Watch the full interview here: ⁣
⁣https://youtu.be/wz6Tv-Va3no?si=LN4S3enENpXESPF2
⁣
Originally aired on 𝐊𝐓𝐍 𝐍𝐞𝐰𝐬’ 𝐘𝐚𝐧𝐚𝐲𝐨𝐣𝐢𝐫𝐢.⁣
⁣

05/08/2026

Every advance in ovarian cancer care begins with shared knowledge.

This Thursday, KESHO welcomes Dr. Chris Gallagher, Medical Oncologist at St. Bartholomew’s Hospital, London, for an engaging CME exploring recent developments in epithelial ovarian cancer.

The session will be moderated by Dr. Amina K. Habib.

Whether you’re involved in oncology, pathology, surgery, nursing, pharmacy or allied healthcare, this is an opportunity to stay current with emerging evidence and evolving clinical practice.

📅 Thursday, 6 August 2026
🕖 7:00 PM – 8:30 PM EAT

Register today:
https://us02web.zoom.us/webinar/register/5415994631625/WN_pKmyRjY3Q4Kq3mlDYzQfdw

30/07/2026

𝐅𝐫𝐨𝐦 𝐭𝐮𝐦𝐨𝐮𝐫 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 𝐭𝐨 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐬𝐞𝐥𝐞𝐜𝐭𝐢𝐨𝐧: 𝐡𝐨𝐰 𝐜𝐚𝐧 𝐩𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐛𝐞 𝐢𝐦𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐞𝐝 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞𝐥𝐲 𝐢𝐧 𝐥𝐨𝐰-𝐚𝐧𝐝 𝐦𝐢𝐝𝐝𝐥𝐞-𝐢𝐧𝐜𝐨𝐦𝐞 𝐜𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬?⁣
⁣
Tonight, KESHO brings together specialists in pathology and clinical oncology to examine the pathway from molecular diagnosis to informed clinical decision-making.⁣
⁣
The CPD-accredited session will explore:⁣
⁣
➡️ The role of pathology, biomarkers and molecular testing in precision oncology.⁣
➡️ The current precision-oncology landscape in LMICs.⁣
➡️ Translating diagnostic findings into clinical decisions.⁣
➡️ Implementation challenges, opportunities and the road ahead.⁣
⁣
Speakers:⁣
𝐏𝐫𝐨𝐟. 𝐒𝐡𝐚𝐡𝐢𝐧 𝐒𝐚𝐲𝐞𝐝⁣
The Diagnostic Foundations of Precision Oncology: Pathology, Biomarkers and Molecular Testing⁣
⁣
𝐏𝐫𝐨𝐟. 𝐂𝐡𝐢𝐭𝐞 𝐀𝐬𝐢𝐫𝐰𝐚⁣
Precision Oncology in LMICs: Current Landscape, Clinical Application and the Road Ahead⁣
⁣
Moderated by 𝐏𝐫𝐨𝐟. 𝐍𝐢𝐜𝐡𝐨𝐥𝐚𝐬 𝐀𝐛𝐢𝐧𝐲𝐚.⁣
⁣
Tonight | 30 July 2026⁣
7:00–8:30 PM EAT⁣
⁣
𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐧𝐨𝐰:
https://us02web.zoom.us/webinar/register/5415994631625/WN_eNuq3sxWTm6uVyqIMLgjQg ⁣
⁣
Join the conversation on moving precision oncology from possibility to practical patient care.⁣

International Cancer InstituteAfrican Organisation for Research and Training in Cancer AF Chite
⁣

23/07/2026

Today’s CME turns the spotlight on neurotoxicity in cancer care.

Neurological complications may arise from the disease itself or as a result of treatment, and recognising them early can make a meaningful difference in patient care.

Join us for a practical discussion on identifying, assessing and managing neurotoxicity across the cancer care pathway.

Register to attend:
https://us02web.zoom.us/webinar/register/5415994631625/WN_KJ0TP2LxSnqFwgjRn98xOA

17/07/2026

Close to 300 participants joined KESHO and the Kenya Cardiac Society for a case-based discussion on protecting cardiovascular health across the cancer treatment journey.⁣
⁣
The discussions brought several practice-changing issues into sharp focus:⁣
⁣
𝟏. 𝐂𝐚𝐫𝐝𝐢𝐨𝐭𝐨𝐱𝐢𝐜𝐢𝐭𝐲 𝐢𝐬 𝐛𝐫𝐨𝐚𝐝𝐞𝐫 𝐭𝐡𝐚𝐧 𝐡𝐞𝐚𝐫𝐭 𝐟𝐚𝐢𝐥𝐮𝐫𝐞.⁣
Cancer therapy may be associated with arrhythmias, hypertension, thrombosis, myocardial ischaemia, myocarditis, pericardial disease, valvular disease and cardiomyopathy.⁣
⁣
𝟐. 𝐁𝐞𝐠𝐢𝐧 𝐛𝐞𝐟𝐨𝐫𝐞 𝐭𝐡𝐞 𝐟𝐢𝐫𝐬𝐭 𝐝𝐨𝐬𝐞.⁣
Cardiovascular risk factors, existing heart disease, previous cancer treatment and the proposed treatment regimen should guide baseline assessment.⁣
⁣
𝟑. 𝐃𝐨 𝐧𝐨𝐭 𝐝𝐢𝐬𝐦𝐢𝐬𝐬 𝐚 𝐫𝐞𝐬𝐨𝐥𝐯𝐞𝐝 𝐬𝐲𝐦𝐩𝐭𝐨𝐦.⁣
Chest pain, breathlessness, palpitations, unexplained bradycardia or a change in functional status may require evaluation before treatment continues.⁣
⁣
𝟒. 𝐀 𝐧𝐨𝐫𝐦𝐚𝐥 𝐞𝐣𝐞𝐜𝐭𝐢𝐨𝐧 𝐟𝐫𝐚𝐜𝐭𝐢𝐨𝐧 𝐝𝐨𝐞𝐬 𝐧𝐨𝐭 𝐚𝐥𝐰𝐚𝐲𝐬 𝐭𝐞𝐥𝐥 𝐭𝐡𝐞 𝐰𝐡𝐨𝐥𝐞 𝐬𝐭𝐨𝐫𝐲.⁣
Global longitudinal strain, ECG findings, cardiac biomarkers and the clinical context can reveal abnormalities before overt heart failure develops.⁣
⁣
𝟓. 𝐒𝐮𝐫𝐯𝐞𝐢𝐥𝐥𝐚𝐧𝐜𝐞 𝐝𝐨𝐞𝐬 𝐧𝐨𝐭 𝐧𝐞𝐜𝐞𝐬𝐬𝐚𝐫𝐢𝐥𝐲 𝐞𝐧𝐝 𝐰𝐢𝐭𝐡 𝐜𝐚𝐧𝐜𝐞𝐫 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭.⁣
Some cardiovascular complications may emerge years later, particularly following anthracyclines, chest radiotherapy, stem cell transplantation and combination therapies.⁣
⁣
Thank you to our moderator Prof Arjun Ghosh and speakers Dr Anne Mwirigi, Dr Kieran Mwazo and Dr Joseph Abuodha for an informative and clinically grounded session.⁣
⁣
This conversation marks an important step towards more coordinated cardio-oncology care in Kenya and the region.⁣
⁣
⁣

Cancer treatment should address more than the disease alone. Protecting cardiovascular health before, during and after treatment is an important part of delivering comprehensive cancer care.⁣
⁣
Tomorrow evening, 𝐊𝐄𝐒𝐇𝐎 and the Kenya Cardiac Society bring together experts in haematology, cardiology and oncology for:⁣
⁣
𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐂𝐚𝐫𝐝𝐢𝐨-𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐢𝐧 𝐄𝐚𝐬𝐭 𝐀𝐟𝐫𝐢𝐜𝐚: 𝐅𝐫𝐨𝐦 𝐄𝐯𝐢𝐝𝐞𝐧𝐜𝐞 𝐭𝐨 𝐄𝐯𝐞𝐫𝐲𝐝𝐚𝐲 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞⁣
⁣
The discussion will explore how current evidence can be translated into practical, coordinated care within the East African setting.⁣
⁣
📅 Thursday, 16 July 2026⁣
🕖 7:00 PM to 8:30 PM EAT⁣
⁣
𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐡𝐞𝐫𝐞:⁣

https://us02web.zoom.us/webinar/register/5415994631625/WN_badEAqvITGuExZWmFfTKag
⁣

15/07/2026

Cancer treatment should address more than the disease alone. Protecting cardiovascular health before, during and after treatment is an important part of delivering comprehensive cancer care.⁣
⁣
Tomorrow evening, 𝐊𝐄𝐒𝐇𝐎 and the Kenya Cardiac Society bring together experts in haematology, cardiology and oncology for:⁣
⁣
𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐂𝐚𝐫𝐝𝐢𝐨-𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐢𝐧 𝐄𝐚𝐬𝐭 𝐀𝐟𝐫𝐢𝐜𝐚: 𝐅𝐫𝐨𝐦 𝐄𝐯𝐢𝐝𝐞𝐧𝐜𝐞 𝐭𝐨 𝐄𝐯𝐞𝐫𝐲𝐝𝐚𝐲 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞⁣
⁣
The discussion will explore how current evidence can be translated into practical, coordinated care within the East African setting.⁣
⁣
📅 Thursday, 16 July 2026⁣
🕖 7:00 PM to 8:30 PM EAT⁣
⁣
𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐡𝐞𝐫𝐞:⁣

https://us02web.zoom.us/webinar/register/5415994631625/WN_badEAqvITGuExZWmFfTKag
⁣